M&A Deal Summary |
|
---|---|
Date | 2021-06-08 |
Target | Alpina Group |
Sector | Insurance |
Buyer(s) | Five Arrows |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
PE ASSETS | 24.0B EUR |
Size | Mega |
Type | Sector Agnostic |
Five Arrows Principal Investments is a mid-cap investor in Western European companies. Five Arrows can invest across the capital structure (equity, equity-linked, mezzanine, convertible debt) and generally focused on primary or secondary buyouts, growth financings, and balance sheet restructurings. The Group does not have any sector preferences, but typically looks for businesses with high barriers to entry and predictable earnings. Five Arrows can commit €30 to €400 million per investment. Five Arrows is a unit of Rothschild Bank. The Group has offices in Paris, Luxembourg, and London.
DEAL STATS | # |
---|---|
Overall | 40 of 55 |
Sector (Insurance) | 3 of 3 |
Type (Buyout (LBO, MBO, MBI)) | 14 of 14 |
Country (Netherlands) | 3 of 4 |
Year (2021) | 2 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-08 |
Heilbron Group
Doetinchem, Netherlands Heilbron Group is a tech-enabled insurance distribution platform in the Netherlands, focused specifically on the small/medium sized enterprises and corporates. Heilbron Group was founded in 1932 and is based in Doetinchem, Netherlands. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-29 |
Sygnature Discovery
Nottingham, United Kingdom Sygnature Discovery is a provider of outsourced drug discovery services to the UK and overseas biotech and pharma companies. Sygnature provides integrated drug discovery and preclinical services to clients across eight key therapeutic areas, including oncology, neuroscience, and inflammation & immunology, and has an outstanding track record of scientific excellence. Sygnature Discovery was founded in 2004 and is based in Nottingham, United Kingdom. |
Buy | - |